Vericel Corporation (formerly Aastrom Biosciences) is currently evaluating its autologous cellular therapies in late-stage U.S. clinical trials in the treatment of dilated cardiomyopathy (DCM). This critical disease is associated with significant morbidity and mortality and very limited treatment options
Location: United States, Massachusetts, Cambridge
Member count: 201-500
Phone: (617) 588-5555
Founded date: 1989
Investors 1
| Date | Name | Website |
| - | Ignite 500 | ignite500.... |
Mentions in press and media 2
| Date | Title | Description | Category | Author | Source |
| 13.09.2018 | Vericel br... | “The issue with cartilage is t... | - | - | medcitynew... |
| - | Vericel br... | Last month, Vericel reported r... | - | - | medcitynew... |